BRIEF-Yuanyi Pharmaceutical Technology Holding Group Co Ltd- Files For Us IPO

BRIEF-Yuanyi Pharmaceutical Technology Holding Group Co Ltd- Files For Us IPO - SEC Filing

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

BRIEF-Yuanyi Pharmaceutical Technology Holding Group Co Ltd- Files For Us IPO - SEC Filing

Jul 10, 2024 3:26 PM

July 10 (Reuters) - Yuanyi Pharmaceutical Technology

Holding Group Co Ltd:

* YUANYI PHARMACEUTICAL TECHNOLOGY HOLDING GROUP CO LTD

FILES FOR

U.S. IPO - SEC FILING

* YUANYI PHARMACEUTICAL TECHNOLOGY HOLDING GROUP CO LTD-

FILES FOR

US IPO- SEC FILING

* YUANYI PHARMACEUTICAL TECHNOLOGY HOLDING GROUP SAYS

APPLIED TO

LIST ORDINARY SHARES ON NASDAQ UNDER SYMBOL " ARDH "

* YUANYI PHARMACEUTICAL TECHNOLOGY HOLDING GROUP CO-IPO OF

ORDINARY SHARES OF OFFERING PRICE OF ORDINARY SHARES IN OFFERING

SEES TO BE $4.00 PER SHARE

Source text for Eikon:

Previous page： Why Albemarle Stock Is Tumbling Tuesday Next page： Baxter International Now Considering Sale of Kidney Care Business to Private Equity Investors

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Why Albemarle Stock Is Tumbling Tuesday

Mar 5, 2024

Albemarle Corp ( ALB ) shares are trading lower Tuesday after the company announced a proposed public offering. What To Know: After the market close on Monday, Albemarle commenced an offering of $1.75 billion of depositary shares in an underwritten registered public offering. The company said it plans to grant the underwriters a 30-day option to purchase up to an additional $262.5 million of its...

Baxter International Now Considering Sale of Kidney Care Business to Private Equity Investors

Mar 5, 2024

10:04 AM EST, 03/05/2024 (MT Newswires) -- Baxter International ( BAX ) is exploring the potential sale of its Kidney Care business with select private equity investors, the health care company said late Monday in a regulatory filing. Baxter said while there has been no final decision about a sale, it continues to expect completing some form of a separation...

Wayfair Insider Sold Shares Worth $1,194,400, According to a Recent SEC Filing

Mar 5, 2024

10:05 AM EST, 03/05/2024 (MT Newswires) -- Thomas Netzer, Chief Operating Officer, on March 01, 2024, sold 20,000 shares in Wayfair ( W ) for $1,194,400. Following the Form 4 filing with the SEC, Netzer has control over a total of 116,622 shares of the company, with 116,622 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1616707/000178325124000006/xslF345X03/wk-form4_1709600301.xml Price: 61.06, Change: -0.25, Percent Change:...

Cadence Design Systems to Buy BETA CAE for $1.24 Billion

Mar 5, 2024

10:04 AM EST, 03/05/2024 (MT Newswires) -- Cadence Design Systems ( CDNS ) said Tuesday it has agreed to buy for $1.24 billion BETA CAE Systems International, a provider of engineering simulation services. Under the terms of the deal, 60% of the amount will be paid in cash and 40% will be paid via the issuance of Cadence common shares...